Gail M Farfel - Net Worth and Insider Trading
Gail M Farfel Net Worth
The estimated net worth of Gail M Farfel is at least $147,954 dollars as of 2024-04-27. Gail M Farfel is the EVP/Chief Development Officer of Zogenix Inc and owns about 5,048 shares of Zogenix Inc (ZGNX) stock worth over $134,681. Gail M Farfel is the Director of Durect Corp and owns about 10,000 shares of Durect Corp (DRRX) stock worth over $9,313. Gail M Farfel is also the CEO of ProMIS Neurosciences Inc and owns about 2,000 shares of ProMIS Neurosciences Inc (PMN) stock worth over $3,960. Besides these, Gail M Farfel also holds Marinus Pharmaceuticals Inc (MRNS) . Details can be seen in Gail M Farfel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gail M Farfel has not made any transactions after 2022-12-14 and currently still holds the listed stock(s).
Transaction Summary of Gail M Farfel
Gail M Farfel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gail M Farfel owns 5 companies in total, including Avrobio Inc (AVRO) , Zogenix Inc (ZGNX) , and Durect Corp (DRRX) among others .
Click here to see the complete history of Gail M Farfel’s form 4 insider trades.
Insider Ownership Summary of Gail M Farfel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVRO | Avrobio Inc | 2020-10-19 | director |
| ZGNX | Zogenix Inc | 2020-06-25 | EVP/Chief Development Officer |
| DRRX | Durect Corp | 2022-05-18 | director |
| MRNS | Marinus Pharmaceuticals Inc | 2015-04-21 | Chief Clinical Dev.Regulatory |
| PMN | ProMIS Neurosciences Inc | 2023-08-23 | director & Chief Executive Officer |
Gail M Farfel Latest Holdings Summary
Gail M Farfel currently owns a total of 4 stocks. Among these stocks, Gail M Farfel owns 5,048 shares of Zogenix Inc (ZGNX) as of May 12, 2020, with a value of $134,681 and a weighting of 91.03%. Gail M Farfel owns 10,000 shares of Durect Corp (DRRX) as of May 18, 2022, with a value of $9,313 and a weighting of 6.29%. Gail M Farfel also owns 2,000 shares of ProMIS Neurosciences Inc (PMN) as of December 14, 2022, with a value of $3,960 and a weighting of 2.68%. The other 1 stocks Marinus Pharmaceuticals Inc (MRNS) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Gail M Farfel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZGNX | Zogenix Inc | 2020-05-12 | 5,048 | 26.68 | 134,681 |
| DRRX | Durect Corp | 2022-05-18 | 10,000 | 0.93 | 9,313 |
| PMN | ProMIS Neurosciences Inc | 2022-12-14 | 2,000 | 1.98 | 3,960 |
| MRNS | Marinus Pharmaceuticals Inc | 2015-04-21 | 0 | 1.41 | 0 |
Holding Weightings of Gail M Farfel
Gail M Farfel Form 4 Trading Tracker
According to the SEC Form 4 filings, Gail M Farfel has made a total of 2 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zogenix Inc is the sale of 2,573 shares on May 12, 2020, which brought Gail M Farfel around $72,584.
According to the SEC Form 4 filings, Gail M Farfel has made a total of 4 transactions in Durect Corp (DRRX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Durect Corp is the acquisition of 5,521 shares on May 18, 2022, which cost Gail M Farfel around $22,084.
According to the SEC Form 4 filings, Gail M Farfel has made a total of 2 transactions in ProMIS Neurosciences Inc (PMN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ProMIS Neurosciences Inc is the acquisition of 1,000 shares on December 14, 2022, which cost Gail M Farfel around $4,940.
More details on Gail M Farfel's insider transactions can be found in the Insider Trading History of Gail M Farfel table.Insider Trading History of Gail M Farfel
- 1
Gail M Farfel Trading Performance
GuruFocus tracks the stock performance after each of Gail M Farfel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gail M Farfel is 52.49%. GuruFocus also compares Gail M Farfel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gail M Farfel within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gail M Farfel's insider trading performs compared to the benchmark.
Performance of Gail M Farfel
Average Return
-7.83%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.29 | 52.49 | 16.19 | -7.83 | ||
| Relative Return to S&P 500(%) | 26.49 | 48.02 | 13.49 | -16.14 |
Gail M Farfel Ownership Network
Ownership Network List of Gail M Farfel
Ownership Network Relation of Gail M Farfel
Gail M Farfel Owned Company Details
What does Avrobio Inc do?
Who are the key executives at Avrobio Inc?
Gail M Farfel is the director of Avrobio Inc. Other key executives at Avrobio Inc include Chief Technology Officer Azadeh Golipour , Chief Medical Officer Essra Ridha , and Chief Scientific Officer Christopher Mason .
Avrobio Inc (AVRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avrobio Inc Insider Transactions
Gail M Farfel Mailing Address
Above is the net worth, insider trading, and ownership report for Gail M Farfel. You might contact Gail M Farfel via mailing address: 142 Temple Street, Suite 205, New Haven Ct 06510.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
